Search
for
Sort by
Research 481–510 of 1000+
- Anthracycline analogs The past, present, and future
- Drug Reactions Affecting Hair: Diagnosis
- Alopecia areata: An update
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata
- Niosomes as Carrier in Dermal Drug Delivery
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Successful Management of Treatment-Resistant Alopecia Areata with Platelet Rich Plasma: A Case Series
- Current and future pharmacotherapy for alopecia areata
- Colistin adorned topical nanoemulsion gel formulation for enhanced anti-microbial activity
- LUPUS VASCULITIS
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Cutaneous drug reactions
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review
- A comparative study on therapeutic efficacy between topical dinitrochlorobenzene and topical betamethasone in alopecia areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Index
- Verrucous hemangioma leg: A challenging birthmark
- Abstracts Pt.30